STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 61 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $12,000 | +9.1% | 4,375 | 0.0% | 0.00% | – |
| Q4 2020 | $11,000 | +22.2% | 4,375 | 0.0% | 0.00% | – |
| Q3 2020 | $9,000 | -60.9% | 4,375 | -26.6% | 0.00% | – |
| Q2 2020 | $23,000 | +228.6% | 5,957 | +54.5% | 0.00% | – |
| Q1 2020 | $7,000 | -46.2% | 3,855 | -36.2% | 0.00% | – |
| Q4 2019 | $13,000 | -7.1% | 6,045 | 0.0% | 0.00% | – |
| Q3 2019 | $14,000 | -26.3% | 6,045 | 0.0% | 0.00% | – |
| Q2 2019 | $19,000 | -52.5% | 6,045 | +31.8% | 0.00% | – |
| Q1 2018 | $40,000 | +21.2% | 4,587 | 0.0% | 0.00% | – |
| Q4 2017 | $33,000 | +50.0% | 4,587 | +44.2% | 0.00% | – |
| Q3 2017 | $22,000 | -4.3% | 3,181 | 0.0% | 0.00% | – |
| Q2 2017 | $23,000 | – | 3,181 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,612,065 | $15,803,000 | 17.82% |
| Prosight Management, LP | 2,515,072 | $6,011,000 | 3.33% |
| 22NW, LP | 804,410 | $1,923,000 | 2.54% |
| Broadfin Capital, LLC | 2,578,003 | $6,161,000 | 1.14% |
| NEA Management Company, LLC | 4,141,308 | $9,898,000 | 0.82% |
| Opaleye Management Inc. | 490,000 | $1,171,000 | 0.42% |
| PA Capital LLC | 152,977 | $366,000 | 0.36% |
| 683 Capital Management, LLC | 923,700 | $2,208,000 | 0.25% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 414,982 | $992,000 | 0.14% |
| Hudson Bay Capital Management LP | 1,475,000 | $3,525,000 | 0.10% |